US82003F1012 - Common Stock
SHARPS TECHNOLOGY INC
NASDAQ:STSS (1/8/2025, 8:00:00 PM)
2.13
-0.1 (-4.48%)
Sharps Technology Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Melville, New York. The company went IPO on 2022-04-14. Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The firm is engaged in offering patented smart-safety syringe products to the healthcare industry. The firm's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. The company Sharps Securegard and Sologard, and Roncadelle SafeR safety syringe product lines incorporate both active and passive safety features and have been designed to address the three primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. The company also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The company has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.
SHARPS TECHNOLOGY INC
105 Maxess Road, Ste. 124
Melville NEW YORK
P: 15162464000
Employees: 57
Website: https://sharpstechnology.com/
Shareholder letter includes details about the $50+ million sales agreement with a US-based pharma company, plans for Hungary SoloGard manufacturing...
Signed multiple agreements to sell its SecureGard syringe inventory, with initial shipments and revenue commencing in early DecemberAgreements also include...
NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and...
NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (
NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical...
Sharps Technology Inc. (NASDAQ: STSS) has closed a secured bridge loan financing of approximately $3.5 million. Investors purchased $4.375 million in aggregate principal amount of secured notes along with 5.7 million shares of common stock. The company plans to use the funds, combined with existing cash, for general corporate purposes and working capital. Aegis Capital Corp. […]
Here you can normally see the latest stock twits on STSS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: